Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $71
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the price target from $65 to $71.

February 01, 2024 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has reaffirmed its Buy rating on Boston Scientific and raised the price target from $65 to $71.
The upgrade in the price target by a reputable analyst like Joanne Wuensch from Citigroup suggests a strong confidence in Boston Scientific's future performance. This is likely to instill positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100